Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: MarketLine (a Datamonitor Company)
$50.00
Provider: MacroRisk Analytics/EconomicInvestor
$25.00
Provider: ValuEngine, Inc.
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Emergent BioSolutions Inc Announces CFO Change-Form 8-K


Monday, 19 Nov 2012 12:44pm EST 

Emergent BioSolutions Inc reported in its Form 8-K that on November 15, 2012, R. Don Elsey, the Chief Financial Officer (CFO) of Emergent BioSolutions Inc. (Company) resigned from the Company effective December 3, 2012. On November 16, 2012, the Company appointed Robert G. Kramer, who is currently the Executive Vice President of the corporate services division of the Company, to the additional roles of Chief Financial Officer, principal financial and accounting officer, and treasurer, also effective December 3, 2012. 

Related Company News

Company Quote

22.93
-0.1 -0.43%
23 Jul 2014